Bid price | 11.10 | Open price | 11.83 |
---|---|---|---|
Ask price | 12.35 | Prev close | 11.73 |
High price | 0.00 | Spread | 10.12% |
Low price | 0.00 | Volume | 0 |
Register now for FREE live Immupharma share prices, Immupharma stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Immupharma Level 2 Data, indepth research tools and investor commentary for Immupharma (IMM) and other London Stock Exchange equities.
Register now for FREE Immupharma share price charts
Name | ImmuPharma | Epic | IMM |
---|---|---|---|
Sector | n/a | ISIN | GB0033711010 |
Activites | n/a | Index | n/a |
Dec.Date | Type | Director | Pos | No. of Shares |
---|---|---|---|---|
07/09/2023 | BUY | Lisa Baderoon | NED | 1,000,000 |
11/08/2022 | BUY | Timothy McCarthy | CH | 1,200,000 |
11/08/2022 | BUY | Timothy Franklin | ED | 400,000 |
11/08/2022 | BUY | Lisa Baderoon | NED | 400,000 |
24/08/2021 | BUY | Timothy Franklin | ED | 125,000 |
RNS Number : 1444H Immupharma PLC 02 December 2020 ImmuPharma PLC ("ImmuPharma" or the "Company") IMMUPHARMA TO PRESENT AT BIOTECH...
RNS Number : 8128G Immupharma PLC 30 November 2020 RNS | eCorporate 30 November 2020 ImmuPharma PLC ("ImmuPharma" or the "Company") Total...
RNS Number : 5422G Immupharma PLC 26 November 2020 RNS / eCorporate 26 November 2020 ImmuPharma PLC...
More Immupharma Company News >>
Register now for FREE Immupharma company news
From today's Times: Tiddler to watch "ImmuPharma, steady at 46p, the biotech group which has a treatment of the disease Lupus in phase II trials, could benefit from the failure this week of trials of rival drug Rituxan. ImmuPharma's housebroker, Panmure Gordon, believes its client may attract...
Register now for FREE Immupharma share price discussions